WallStSmart

Medtronic PLC (MDT)vsTaseko Mines Ltd (TGB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 5173% more annual revenue ($35.48B vs $672.90M). MDT leads profitability with a 13.0% profit margin vs -4.5%. TGB appears more attractively valued with a PEG of 0.33. MDT earns a higher WallStSmart Score of 58/100 (C).

MDT

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 6.7Quality: 5.0

TGB

Hold

48

out of 100

Grade: D+

Growth: 6.7Profit: 3.0Value: 5.7Quality: 3.0
Piotroski: 2/9Altman Z: 0.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTUndervalued (+27.7%)

Margin of Safety

+27.7%

Fair Value

$107.79

Current Price

$76.15

$31.64 discount

UndervaluedFair: $107.79Overvalued
TGBSignificantly Overvalued (-17.4%)

Margin of Safety

-17.4%

Fair Value

$7.11

Current Price

$7.49

$0.38 premium

UndervaluedFair: $7.11Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$100.09B9/10

Large-cap with strong market position

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

TGB2 strengths · Avg: 10.0/10
PEG RatioValuation
0.3310/10

Growing faster than its price suggests

Revenue GrowthGrowth
45.3%10/10

Revenue surging 45.3% year-over-year

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

TGB4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.583/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-4.7%2/10

ROE of -4.7% — below average capital efficiency

EPS GrowthGrowth
-45.5%2/10

Earnings declined 45.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bull Case : TGB

The strongest argument for TGB centers on PEG Ratio, Revenue Growth. Revenue growth of 45.3% demonstrates continued momentum. PEG of 0.33 suggests the stock is reasonably priced for its growth.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : TGB

The primary concerns for TGB are Debt/Equity, Piotroski F-Score, Return on Equity. Debt-to-equity of 1.58 is elevated, increasing financial risk.

Key Dynamics to Monitor

MDT profiles as a value stock while TGB is a hypergrowth play — different risk/reward profiles.

TGB carries more volatility with a beta of 2.02 — expect wider price swings.

TGB is growing revenue faster at 45.3% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (58/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Taseko Mines Ltd

BASIC MATERIALS · COPPER · USA

Taseko Mines Limited, a mining company, acquires, develops and operates mineral properties. The company is headquartered in Vancouver, Canada.

Visit Website →

Want to dig deeper into these stocks?